🇺🇸 FDA

Intelligence · Patent portfolio

ENANTA PHARMACEUTICALS Patents

Full USPTO pharma patent portfolio for ENANTA PHARMACEUTICALS — grant dates, expiration, and drug cross-links.

Patents
218
Expiring ≤24m
9

Quick answer

ENANTA PHARMACEUTICALS has 218 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 9 expire within 24 months — use filters for patent-cliff planning.

Page 4 of 5

  1. US 8426458

    Hepatitis C Virus inhibitors

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8420596

    Macrocyclic hepatitis C serine protease inhibitors

    Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8420686

    Linked diimidazole antivirals

    Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8383785

    Anti-bacterial activity of 9-hydroxy derivatives of 6,11-bicyclolides

    Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8383583

    Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors

    Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8377872

    Cyclic P3 tripeptide hepatitis C serine protease inhibitors

    Expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8372802

    Fluorinated macrocyclic compounds as hepatitis C virus inhibitors

    Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8367053

    Cyclosporin analogues

    Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8367618

    Cyclosporin analogues for preventing or treating hepatitis C infection

    Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8361958

    Oximyl HCV serine protease inhibitors

    Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8354383

    6,11-bridged biaryl macrolides

    Expires Mon Jan 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8349312

    Proline substituted cyclosporin analogues

    Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8324155

    Quinoxaline-containing compounds as hepatitis C virus inhibitors

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8314135

    Linked dibenzimidazole antivirals

    Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8304385

    Macrocyclic tetrazolyl hepatitis C serine protease inhibitors

    Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8283309

    Bridged carbocyclic oxime hepatitis C virus serine protease inhibitors

    Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8273709

    Triazole-containing macrocyclic HCV serine protease inhibitors

    Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8268777

    Oximyl macrocyclic derivatives

    Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8268776

    Macrocylic oximyl hepatitis C protease inhibitors

    Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8263549

    C5-substituted, proline-derived, macrocyclic hepatitis C serine protease inhibitors

    Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8242156

    Linked dibenzimidazole derivatives

    Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8236807

    Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

    Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8221737

    Hepatitis C virus inhibitors

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8222203

    Macrocyclic oximyl hepatitis C serine protease inhibitors

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8211891

    Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitors

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8188132

    Linked dibenzimidazole derivatives

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8178531

    Antiviral agents

    Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8163707

    4′-allene-substituted nucleoside derivatives

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8124584

    Macrocyclic hepatitis C serine protease inhibitors

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8101643

    Benzimidazole derivatives

    Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8101567

    Heteroaryl-containing tripeptide HCV serine protease inhibitors

    Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8030307

    Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 protease

    Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7910587

    Quinoxalinyl dipeptide hepatitis C virus inhibitors

    Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7906513

    Hydrazide-containing hepatitis C serine protease inhibitors

    Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7728148

    Acyclic oximyl hepatitis C protease inhibitors

    Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7718769

    Tri-peptide hepatitis C serine protease inhibitors

    Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7718612

    Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors

    Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7687459

    Arylalkoxyl hepatitis C virus protease inhibitors

    Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7662779

    Triazolyl macrocyclic hepatitis C serine protease inhibitors

    Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7635683

    Quinoxalinyl tripeptide hepatitis C virus inhibitors

    Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7605126

    Acylaminoheteroaryl hepatitis C virus protease inhibitors

    Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7601709

    Macrocyclic hepatitis C serine protease inhibitors

    Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7582605

    Phosphorus-containing hepatitis C serine protease inhibitors

    Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7566719

    Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

    Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7468419

    Cyclosporin derivatives for the treatment of immune disorders

    Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7419962

    3,6-bicyclolides

    Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7384921

    Polymorphic forms of 6-11 bicyclic ketolide derivatives

    Expires Mon Jun 05 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7368452

    Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

    Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does ENANTA PHARMACEUTICALS have?

218 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do ENANTA PHARMACEUTICALS patents expire?

9 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.